Risk for Skin Infections May Be Increased With Statin Use
Using statins for as short a time as three months can put patients at risk for developing diabetes and skin and soft tissue infections.
Using statins for as short a time as three months can put patients at risk for developing diabetes and skin and soft tissue infections.
A review finds that fluconazole is the only commercially available evidence-based option for systemic treatment of cutaneous candidiasis.
Patients with 30-day postoperative infection have an increased risk for long-term infection and mortality.
Orthopedic surgeons should be vigilant when managing periarticular knee fracture repairs.
The FDA has expanded the indication for Teflaro (ceftaroline fosamil; Allergan) to include treatment of acute bacterial skin and skin structure infections in pediatric patients.
Using a broad-range PCR technique targeting 16S ribosomal DNA may improve diagnosis and treatment of bacterial pyomyositis.
New data demonstrate that long-term tetracycline use in patients on epidermal growth factor receptor inhibitor treatment is associated with increased rates of SSTI and MRSA.
No evidence exists to support the superiority of any one antibiotic for the treatment of cellulitis — although short treatment courses of antibiotics appear to be as effective as longer treatment courses.
The association of S aureus with food sensitization and allergy could influence interventions aimed at inducing and maintaining tolerance to food allergens in eczematous infants.
Prediction of sepsis via markers such as hypothermia and elevated procalcitonin
may allow for its early detection and management.